Freedom from Thromboembolism
Author | Year | No. of Patients |
Type of Study |
Type of Valve |
Mean Age at Implant | Mean Follow-Up (yrs) |
5 years (%) |
10 years (%) |
15 years (%) |
20 years (%) |
25 years (%) |
Linearized rate (% per pt year) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Khan et al, | 1998 | 248 | Retrospective | Hancock Porcine | 64 | 7.3 | - | - | 81 | - | - | - |
Poirier et al, | 1998 | 149 | Prospective Follow-Up | *CE bovine pericardial | 65 | 4.8 | 93 | 93 | - | - | - | 1.4 |
Jamieson et al, | 1999 | 1266 | Prospective Follow-Up | CE supra-annular porcine | 64 | 7.3 | - | - | - | - | - | - |
Jamieson et al, | 1999 | 429 | Prospective Follow-Up | CE perimount pericardial | 61 | 7.3 | - | - | - | - | - | - |
David et al, | 2001 | 310 | Prospective Follow-Up | Hancock II porcine | 65 | 6.9 | - | - | 87 | - | - | - |
Marchand et al, | 2001 | 435 | Prospective Follow-Up | CE perimount pericardial | 61 | 8.1 | - | - | 84 (14yr) | - | - | 1.1 |
Rizzoli et al, | 2006 | 484 | Prospective Follow-Up | Hancock II porcine | 66 | 12 | 93 | 85 | 72 | - | - | 1.8 |
Jamieson et al, | 2009 | 1135 | Prospective Follow-Up | CE supra-annular porcine | 65 | 6.4 | - | - | - | 72 (18yr) | - | 3.3 |
Myken et al, | 2009 | 194 | Prospective Follow-Up | St. Jude Medical Biocor | 65 | 6.2 | - | - | - | 71 | - | 2.2 |
Riess et al, | 2010 | 47 | Prospective Follow-Up | Medtronic Mosaic porcine | 67 | 8.2 | 100 (4yr) | 92 (8yr) | 92 (13yr) | - | - | 0.6 |
Jamieson et al, | 2011 | 232 | Prospective Follow-Up | Medtronic Mosaic porcine | 67 | 7.3 | - | - | - | - | - | - |
Aaron J. Weiss M.D., Stephen M. Spindel M.D., and Farzan Filsoufi M.D.
- Khan SS, Chaux A, Blanche C, et al. A 20-year experience with the Hancock porcine xenograft in the elderly. Ann Thorac Surg 1998;66:S35-9.
- Poirier NC, Pelletier LC, Pellerin M, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998;66:S57-61.
- Jamieson WR, Marchand MA, Pelletier CL, et al. Structural valve deterioration in mitral replacement surgery: comparison of Carpentier-Edwards supra-annular porcine and perimount pericardial bioprostheses. J Thorac Cardiovasc Surg 1999;118:297-304.
- David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-77.
- Marchand MA, Aupart MR, Norton R, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001;71:S236-9.
- Rizzoli G, Mirone S, Ius P, et al. Fifteen-year results with the Hancock II valve: a multicenter experience. J Thorac Cardiovasc Surg 2006;132:602-9, 609 e1-4.
- Jamieson WR, Gudas VM, Burr LH, et al. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement? Eur J Cardiothorac Surg 2009;35:104-10.
- Myken PS, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 2009;137:76-81.
- Riess FC, Cramer E, Hansen L, et al. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg 2010;37:145-53.
- Jamieson WR, Riess FC, Raudkivi PJ, et al. Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg 2011;142:302-7 e2.